Quick Answer
Coherus Oncology, Inc. reported Common Stock Shares Outstanding of 121.15 million shares for the year ending 2025.
- Coherus Oncology, Inc. showed an increase of +4.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Coherus Oncology, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Coherus Oncology, Inc.'s Common Stock Shares Outstanding has grown by 2,404.4%.
- Historical annual values: Fiscal year 2025: 121.15 million shares | Fiscal year 2024: 115.61 million shares | Fiscal year 2023: 112.22 million shares | Fiscal year 2022: 78.85 million shares | Fiscal year 2021: 76.93 million shares | Fiscal year 2020: 72.51 million shares | Fiscal year 2019: 70.37 million shares | Fiscal year 2018: 68.30 million shares | Fiscal year 2017: 59.84 million shares | Fiscal year 2016: 45.81 million shares | Fiscal year 2015: 39.01 million shares | Fiscal year 2014: 33.26 million shares | Fiscal year 2013: 4.84 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: